TIL Q3 2025 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$62M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$12,000

Operating Income

-$15M

Net Income

-$14M

EPS (Diluted)

$-2.01

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$11M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$212M

Total Liabilities

$91M

Stockholders' Equity

$120M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$12,000	$0	—
Operating Income	-$15M	-$24M	+36.4%
Net Income	-$14M	-$23M	+41.0%